Literature DB >> 32767939

Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products.

Amir R Afshari1, Hamid Mollazadeh2, Mohammad Soukhtanloo3, Azar Hosseini4, Elmira Mohtashami3, Mohammad Jalili-Nik3, Seyed Mohamad Sadegh Modaresi5, Arash Soltani3, Amirhossein Sahebkar6.   

Abstract

Glioblastoma multiforme (GBM) continues as one of the most lethal cerebral cancers despite standard therapeutic modalities, such as maximum surgical resection and chemoradiation. The minimal effectiveness of existing therapies necessitates the development of additional drug candidates that could improve the prognosis of GBM patients. Accumulating evidence suggests that calcium (Ca2+) is involved in the processes of cell proliferation, metastasis, angiogenesis, migration, and invasiveness. Therefore, Ca2+ could serve as a crucial regulator of tumorigenesis and a potential treatment target in GBM. In this context, specific natural products are known to modulate Ca2+ signaling pathways implicated in tumor growth, apoptosis, angiogenesis, and development of GBM. Here, the focus is on the function of Ca2+ as a therapeutic target in GBM and reviewing certain natural products that affect the signaling pathways of Ca2+. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Glioblastoma multiforme; angiogenesis; apoptosis; calcium; metastasis; natural products

Mesh:

Substances:

Year:  2020        PMID: 32767939     DOI: 10.2174/1389557520666200807133659

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  1 in total

1.  Thymol has anticancer effects in U-87 human malignant glioblastoma cells.

Authors:  Farid Qoorchi Moheb Seraj; Niloofar Heravi-Faz; Arash Soltani; Seyed Sajad Ahmadi; Fatemeh Shahbeiki; Amir Talebpour; Amir R Afshari; Gordon A Ferns; Afsane Bahrami
Journal:  Mol Biol Rep       Date:  2022-08-23       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.